VEGFR-2-IN-10 exhibits increased antiangiogenic potency ( IC 50 = 0.7 μM) against VEGF-induced VEGFR2 phosphorylation without cytotoxic effects.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > VEGFR
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。